Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Nutriband

    Client Virtual Booth

    NUTRIBAND

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Nutriband
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    121 S. Orange Ave., Suite 1500, Orlando, FL 32801
    Telephone
    Telephone
    +1 (407) 377 6696
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nutriband.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nutriband/
    Twitter
    Twitter
    https://twitter.com/Nutriband/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Nutriband Inc. Announces $8.4M Private Placement
    Nutriband Inc. Announces $8.4M Private Placement

    https://www.accesswire.com/854758/nutriband-inc-announces-84m-private-placement

    ACCESSWIRE
    19 Apr 2024
    Share Share
    Nutriband Begins Manufacturing for Major Sports Brand Licensee Fit for Life Grp
    Nutriband Begins Manufacturing for Major Sports Brand Licensee Fit for Life Grp

    https://www.accesswire.com/848510/nutriband-inc-begins-manufacturing-for-major-sports-brand-licensee-fit-for-life-group-whose-collection-of-partnered-brands-include-reebok-addidas-and-new-balance

    ACCESSWIRE
    01 Apr 2024
    Share Share
    Nutriband Provides Clinical Overview for Lead Product - AVERSA(R)
    Nutriband Provides Clinical Overview for Lead Product - AVERSA(R)

    https://www.accesswire.com/847227/nutriband-provides-clinical-and-regulatory-path-overview-for-lead-product-aversar-fentanyl-transdermal-patch

    ACCESSWIRE
    27 Mar 2024
    Share Share
    Nutriband Announces Data Supporting Need for Safer AD Transdermal Patches
    Nutriband Announces Data Supporting Need for Safer AD Transdermal Patches

    https://www.accesswire.com/846063/nutriband-announces-data-supporting-need-for-safer-abuse-deterrent-transdermal-patches-presented-at-2024-american-academy-of-pain-medicine-annual-meeting

    ACCESSWIRE
    25 Mar 2024
    Share Share
    Nutriband’s Aversa(TM) Buprenoprhine May Reach Annual Sales of $70-130 Million
    Nutriband’s Aversa(TM) Buprenoprhine May Reach Annual Sales of $70-130 Million

    https://www.accesswire.com/viewarticle.aspx?id=791744&lang=en

    ACCESSWIRE
    11 Oct 2023
    Share Share
    Nutriband Inc. Reports Second Quarter 2023 Financial Results
    Nutriband Inc. Reports Second Quarter 2023 Financial Results

    https://www.accesswire.com/viewarticle.aspx?id=782616&lang=en

    ACCESSWIRE
    11 Sep 2023
    Share Share
    Nutriband Increases Credit Line to $5 Million USD for AVERSA(TM) Platform
    Nutriband Increases Credit Line to $5 Million USD for AVERSA(TM) Platform

    https://www.accesswire.com/viewarticle.aspx?id=767926&lang=en

    ACCESSWIRE
    14 Jul 2023
    Share Share
    Nutriband Receives Notice of Allowance for U.S. Patent Covering
    Nutriband Receives Notice of Allowance for U.S. Patent Covering

    https://www.accesswire.com/viewarticle.aspx?id=763319&lang=en

    ACCESSWIRE
    23 Jun 2023
    Share Share
    Nutriband with Kindeva Drug Delivery select Aversa™ Fentanyl abuse deterrent formulation for commercial scale manufacturing process development
    Nutriband with Kindeva Drug Delivery select Aversa™ Fentanyl abuse deterrent formulation for commercial scale manufacturing process development

    https://www.kindevadd.com/nutriband-with-kindeva-drug-delivery-select-aversa-fentanyl-abuse-deterrent-formulation-for-commercial-scale-manufacturing-process-development/

    PRESS RELEASE
    04 Apr 2023
    Share Share
    Nutriband With Kindeva Drug Delivery Select Aversa Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development
    Nutriband With Kindeva Drug Delivery Select Aversa Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development

    https://www.accesswire.com/viewarticle.aspx?id=747394&lang=en

    ACCESSWIRE
    04 Apr 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search